Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

A novel active driving system for paediatric ventricular assist devices exhibits safety and reliability in children with heart failure, with no major malfunctions, according to a study.

Lack of workplace support tied to burnout among SG health professionals

A perceived lack of workplace support and less time residing in Singapore appear to contribute to the development of burnout among Allied Health Professionals (AHPs) in the post-COVID era, suggests a local study.

Major morbidity rife in single ventricle patients

Death or major morbidity is prevalent in patients with single ventricles, reveals a study.

Adjunctive HBOT beneficial for DFUs

A meta-analysis presented at ADA 2026 supports the benefits of hyperbaric oxygen therapy (HBOT) for ulcer healing and reducing the risk of major amputation in individuals with diabetic foot ulcers (DFUs).

23 Jun 2026

Glucose-lowering therapy tied to reduced risk of depression in T2D

Exposure to several glucose-lowering drugs appears to have a protective effect on the risk of depression in individuals with type 2 diabetes (T2D), according to a population-based cohort study in Hong Kong.

ARACOG: Is there a difference in cognitive effects between darolutamide and enzalutamide?

ARACOG, a phase II randomized trial, reports a significantly greater decline in objectively assessed cognitive function for advanced prostate cancer patients treated with enzalutamide vs darolutamide over 24 weeks, according to data presented at ASCO 2026.

23 Jun 2026

Chiauranib extends PFS in platinum-resistant ovarian cancer, including in anti-angio–exposed patients

Chiauranib plus weekly paclitaxel significantly extends progression-free survival (PFS) in patients with platinum-resistant or -refractory ovarian cancer, including those previously treated with anti-angiogenic agents, according to the findings of the phase III CHIPRO trial presented at ASCO 2026.

23 Jun 2026

Relative fat mass predicts stroke

Relative fat mass is strongly associated with incident stroke, especially ischaemic stroke, as shown in a study.

Ocrelizumab slows hand function decline in multiple sclerosis patients

22 Jun 2026 bởi

Treatment with ocrelizumab helps delay progression of disability, especially of the upper limb, in a broad population of patients with primary progressive multiple sclerosis (PPMS), including those who are older and have more advanced disease, according to the phase 3b ORATORIO-HAND trial.

Liver transplant recipients at increased risk of coronary atherosclerosis

The prevalence and severity of coronary atherosclerosis are significantly higher among recipients of liver transplant than the general population, a study has shown.